🔎 Trials Near Me

Hjem › Idiopatisk trombocytopenisk purpura › New York

Kliniske studier for Idiopatisk trombocytopenisk purpura i New York

7 studier for Idiopatisk trombocytopenisk purpura søker deltakere på steder i New York.

Byer i New York

Offisiell studietekst (engelsk)

A Study to Assess the Tolerability of Ianalumab (VAY736) With Investigator's Choice Thrombopoietin Receptor Agonist (IC TPO-RA) in Patients With Primary Immune Thrombocytopenia (ITP)

  • Montefiore Medical Center, The Bronx
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 2. okt. 2026 · NCT07421167

A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

  • Memorial Sloan Kettering Cancer Center, New York
  • Montefiore Medical Center, The Bronx
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 18. sep. 2026 · NCT06722235

Study to Assess the Safety and Tolerability of Tafasitamab in Adult Participants With Primary Autoimmune Blood Cell Disorders

  • Montefiore Medical Center, The Bronx
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 14. sep. 2026 · NCT07104565

A Study Investigating Intravenous Human Normal Immunoglobulin 10% in Adults With Chronic Immune Thrombocytopenia (ITP)

  • NY Cancer and Blood Specialists, Shirley
RekruttererFase 3
Alder 18 til 70 · Alle kjønn · Oppdatert 11. sep. 2026 · NCT07059000

A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

  • Memorial Sloan Kettering Cancer Center, New York
  • Montefiore Medical Center, The Bronx
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 9. sep. 2026 · NCT06948318

Study to Evaluate the Efficacy and Safety of Oral Rilzabrutinib in Adults With Immune Thrombocytopenia (ITP) Who Failed First-line Treatment

  • New York Oncology Hematology-Investigational Site Number: 8400010, Albany
  • Montefiore Medical Center-Investigational Site Number: 8400012, The Bronx
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 22. jun. 2026 · NCT07007962

Dose Dense Rituximab for High Risk Newly Diagnosed Acute Immune Thrombocytopenic Purpura

  • New York Medical College, Vahalla
RekruttererFase 1
Alder 1 til 21 · Alle kjønn · Oppdatert 15. apr. 2026 · NCT04323748

Fra ClinicalTrials.gov, data hentet 7. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.